AV fistula health continuous verification
Hemodialysis (HD) is a vital treatment for patients with chronic kidney disease. Vascular access (VA) is essential to ensure the quality of HD and patient survival. VA dysfunction is frequent and significantly increases the risk of morbidity and mortality. Maintaining these accesses represents 25% of HD costs - approximately ~€300 per patient/month [1,2].
Pulse-HD is a personal device that detects microvibration patterns in the VA, using computational models to predict dysfunction. Our revenues include sales, subscriptions and partnerships with HD centers.
[1] Johansen KL, Gilbertson DT, Li S, Li S, Liu J, Roetker NS, Ku E, Schulman IH, Greer RC, Chan K, Abbott KC, Butler CR, O'Hare AM, Powe NR, Reddy YNV, Snyder J, St Peter W, Taylor JS, Weinhandl ED, Wetmore JB. US Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2024 Apr;83(4 Suppl 1): A8-A13. doi: 10.1053/j.ajkd.2024.01.001. PMID: 38519262.
[2] Eur J Vasc Endovasc Surg. 2013 Jan;45(1):84-92. doi: 10.1016/j.ejvs.2012.10.012. Epub 2012 Nov 13. PMID: 23153926.
Luís Rodrigues
Nephrologist
José Queiroz
Physics Engineer
João Marcos
Telecom Engineer
2nd place in the ArriscaC 2025 edition
Innovation
ARRISCA C is a Business Ideas Competition, organized by the University of Coimbra, with a history of 12 editions, which rewards science/technology-based business ideas, at a national level, that have an impact in various areas.
